Coexistence of a Novel NBAS-ALK, EML4-ALK Double-Fusion in a Lung Adenocarcinoma Patient With LM and Response to Ensartinib

被引：0
作者：
Xu, X. [1 ,2 ,3 ]
Li, N. [1 ]
Fan, Y. [1 ,2 ]
机构：
[1] Univ Chinese Acad Sci, Canc Hosp, Zhejiang Canc Hosp, Hangzhou, Peoples R China
[2] Chinese Acad Sci, Hangzhou, Peoples R China
[3] Zhejiang Chinese Med Univ, Hangzhou, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2022年 / 17卷 / 09期
关键词：
ALK; non-small cell lung cancer (NSCLC); leptomeningeal metastases (LM);
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP08.02-09
引用
收藏
页码：S445 / S445
页数：1
相关论文
共 50 条
[21]   Synergistic effects of crizotinib and radiotherapy in experimental EML4-ALK fusion positive lung cancer [J].
Dai, Ying ;
Wei, Quanxiang ;
Schwager, Christian ;
Moustafa, Mahmoud ;
Zhou, Cheng ;
Lipson, Kenneth E. ;
Weichert, Wilko ;
Debus, Juergen ;
Abdollahi, Amir .
RADIOTHERAPY AND ONCOLOGY, 2015, 114 (02) :173-181
[22]   Ensartinib as a neoadjuvant therapy for stage IIIA non-small cell lung cancer patients with EML4-ALK fusion: a case report and literature review [J].
Zhang, Hao ;
Xia, Wei ;
Zhang, Yifan ;
Bao, Shihao ;
Zeng, Jingtong ;
Li, Xianjie ;
Zhang, Bo ;
Wang, Hanqing ;
Xu, Song ;
Song, Zuoqing .
FRONTIERS IN ONCOLOGY, 2025, 15
[23]   Clinicopathologic Features of Non-Small-Cell Lung Cancer with EML4-ALK Fusion Gene [J].
Takahashi, Tsuyoshi ;
Sonobe, Makoto ;
Kobayashi, Masashi ;
Yoshizawa, Akihiko ;
Menju, Toshi ;
Nakayama, Ei ;
Mino, Nobuya ;
Iwakiri, Shotaro ;
Sato, Kiyoshi ;
Miyahara, Ryo ;
Okubo, Kenichi ;
Manabe, Toshiaki ;
Date, Hiroshi .
ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (03) :889-897
[24]   Bilateral breast adenocarcinomas with EML4-ALK fusion in a patient with multiple metastases successfully treated with crizotinib: is lung the primary site? [J].
Liu, Chao ;
Ding, Lijuan ;
Sun, Bing ;
Wu, Shikai .
ONCOTARGETS AND THERAPY, 2016, 9 :3589-3593
[25]   EML4-ALK Translocation Predicts Better Outcome in Lung Adenocarcinoma Patients with Wild-Type EGFR [J].
Wu, Shang-Gin ;
Kuo, Yao-Wen ;
Chang, Yih-Leong ;
Shih, Jin-Yuan ;
Chen, Ya-Hui ;
Tsai, Meng-Feng ;
Yu, Chong-Jen ;
Yang, Chih-Hsin ;
Yang, Pan-Chyr .
JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (01) :98-104
[26]   Analysis of EGFR, EML4-ALK, KRAS, and c-MET mutations in Chinese lung adenocarcinoma patients [J].
Xia, Ning ;
An, Jian ;
Jiang, Qing-qing ;
Li, Min ;
Tan, Jun ;
Hu, Cheng-ping .
EXPERIMENTAL LUNG RESEARCH, 2013, 39 (08) :328-335
[27]   A Novel Mechanism of EML4-ALK Rearrangement Mediated by Chromothripsis in a Patient-Derived Cell Line [J].
Kodama, Tatsushi ;
Motoi, Noriko ;
Ninomiya, Hironori ;
Sakamoto, Hiroshi ;
Kitada, Kunio ;
Tsukaguchi, Toshiyuki ;
Satoh, Yasuko ;
Nomura, Kimie ;
Nagano, Hiroko ;
Ishii, Nobuya ;
Terui, Yasuhito ;
Hatake, Kiyohiko ;
Ishikawa, Yuichi .
JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (11) :1638-1646
[28]   Lung adenocarcinoma harboring complex EML4-ALK fusion and BRAF V600E co-mutation responded to alectinib [J].
Guo, Weihong ;
Liang, Jianping ;
Zhang, Dandan ;
Huang, Xikun ;
Lv, Yanhua .
MEDICINE, 2022, 101 (40) :E30913
[29]   Differential protein stability and clinical responses of EML4-ALK fusion variants to various ALK inhibitors in advanced ALK-rearranged non-small cell lung cancer [J].
Woo, C. G. ;
Seo, S. ;
Kim, S. W. ;
Jang, S. J. ;
Park, K. S. ;
Song, J. Y. ;
Lee, B. ;
Richards, M. W. ;
Bayliss, R. ;
Lee, D. H. ;
Choi, J. .
ANNALS OF ONCOLOGY, 2017, 28 (04) :791-797
[30]   Novel Human-derived EML4-ALK Fusion cell lines identify ribonucleotide reductase RRM2 as a Target of Activated ALK in NSCLC [J].
Umapathy, G. ;
Bokhari, A. ;
Lai, W. -Y. ;
Le, A. ;
Chuang, T. -P. ;
Fransson, S. ;
Martinsson, T. ;
Van den Eynden, J. ;
Doebele, R. ;
Palmer, R. H. ;
Hallberg, B. .
JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) :S591-S591
12345